Skip to main content

Published locations for HER2-low metastatic BC: Phase 3 establishes trastuzumab deruxtecan as a new standard-of-care

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-low metastatic BC: Phase 3 establishes trastuzumab deruxtecan as a new standard-of-care

User login

  • Reset your password
  • /content/her2-low-metastatic-bc-phase-3-establishes-trastuzumab-deruxtecan-new-standard-care
  • /hematology-oncology/article/256507/breast-cancer/her2-low-metastatic-bc-phase-3-establishes
  • /breast-cancer-icymi/article/256507/breast-cancer/her2-low-metastatic-bc-phase-3-establishes